• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于刺激响应材料的纳米药物递送系统治疗肺部疾病的研究进展

Research progress of nano-based drug delivery systems based on stimuli-responsive materials for the treatment of lung diseases.

作者信息

Li Wenqiang, Huang Qian, Li Mei, Wen Youli, Chen Zhao, Fan Yuting, Shen Chen, Gong Chen, Luo Yao, Deng Zhiping

机构信息

Department of Pulmonary and Critical Care Medicine, Zigong First People's Hospital, Zigong, China.

Department of Pulmonary and Critical Care Medicine, Dazhou Dachuan District People's Hospital (Dazhou Third People's Hospital), Dazhou, China.

出版信息

Front Bioeng Biotechnol. 2025 Jul 31;13:1644007. doi: 10.3389/fbioe.2025.1644007. eCollection 2025.

DOI:10.3389/fbioe.2025.1644007
PMID:40821672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12350321/
Abstract

Since the lungs are directly connected to the external environment and have a rich blood supply, they are susceptible to damage and tumor growth. However, the pharmacokinetics of traditional drugs in the lungs are limited when administered orally or intravenously, posing challenges for clinical treatment. Compared to traditional drug delivery methods, nano-based drug delivery systems (NDDSs) have the advantages of high drug loading capacity, strong targeting, low cellular toxicity, and extended circulation time in the blood. Stimuli-responsive materials, often referred to as "smart" materials, are a class of functional materials that can change their properties in response to various stimuli in both internal and external environments. Therefore, stimuli-responsive materials have gradually become promising candidates for NDDSs. To date, many stimuli-responsive NDDSs have been developed for treating lung diseases. Our review primarily summarizes the novel NDDSs that have emerged in recent years for treating common benign and malignant lesions in the lungs, based on stimuli-responsive materials. Finally, we discussed the existing issues in stimuli-responsive NDDSs and looked forward to their future development prospects.

摘要

由于肺部直接与外部环境相连且血液供应丰富,它们易受损伤和肿瘤生长的影响。然而,传统药物经口服或静脉给药时在肺部的药代动力学有限,给临床治疗带来挑战。与传统药物递送方法相比,基于纳米的药物递送系统(NDDSs)具有载药量高、靶向性强、细胞毒性低以及在血液中循环时间延长等优点。刺激响应材料,通常被称为“智能”材料,是一类能够在内部和外部环境中响应各种刺激而改变其性质的功能材料。因此,刺激响应材料已逐渐成为NDDSs的有前景的候选材料。迄今为止,已经开发了许多用于治疗肺部疾病的刺激响应性NDDSs。我们的综述主要总结了近年来基于刺激响应材料出现的用于治疗肺部常见良性和恶性病变的新型NDDSs。最后,我们讨论了刺激响应性NDDSs中存在的问题,并展望了它们未来的发展前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4501/12350321/4b64826b74fc/fbioe-13-1644007-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4501/12350321/4b64826b74fc/fbioe-13-1644007-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4501/12350321/4b64826b74fc/fbioe-13-1644007-g001.jpg

相似文献

1
Research progress of nano-based drug delivery systems based on stimuli-responsive materials for the treatment of lung diseases.基于刺激响应材料的纳米药物递送系统治疗肺部疾病的研究进展
Front Bioeng Biotechnol. 2025 Jul 31;13:1644007. doi: 10.3389/fbioe.2025.1644007. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Sexual Harassment and Prevention Training性骚扰与预防培训
5
Short-Term Memory Impairment短期记忆障碍
6
Information-Providing Magnetic Supraparticles: Particle Designs to Record Environmental Stimuli with Readout by Magnetic Particle Spectroscopy.信息提供磁性超粒子:通过磁性粒子光谱读出记录环境刺激的粒子设计
Acc Mater Res. 2025 May 23;6(7):842-852. doi: 10.1021/accountsmr.5c00027. eCollection 2025 Jul 25.
7
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
8
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.疾病轨迹的生活经历、治疗负担和社会不平等如何影响服务使用者和照顾者参与健康和社会护理:一项基于理论的定性证据综合分析
Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159.
9
Photomechanical B←N Molecular Crystals: From Single-Crystal-to-Single-Crystal [2 + 2] Photodimerization to Polymerization.光机械B←N分子晶体:从单晶到单晶的[2 + 2]光二聚化到聚合反应
Acc Chem Res. 2025 Sep 2;58(17):2724-2736. doi: 10.1021/acs.accounts.5c00407. Epub 2025 Aug 16.
10
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.评估慢性阻塞性肺疾病干预措施的比较效果:面向临床医生的网状Meta分析教程
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.

本文引用的文献

1
Advancing cancer therapy: Nanomaterial-based encapsulation strategies for enhanced delivery and efficacy of curcumin.推进癌症治疗:基于纳米材料的包封策略以增强姜黄素的递送及疗效
Mater Today Bio. 2025 Jun 9;33:101963. doi: 10.1016/j.mtbio.2025.101963. eCollection 2025 Aug.
2
Inhalable neutrophil-mimicking nanoparticles for chronic obstructive pulmonary disease treatment.用于慢性阻塞性肺疾病治疗的可吸入中性粒细胞模拟纳米颗粒。
J Control Release. 2025 May 10;381:113648. doi: 10.1016/j.jconrel.2025.113648. Epub 2025 Mar 19.
3
Nanomedicines for Pulmonary Drug Delivery: Overcoming Barriers in the Treatment of Respiratory Infections and Lung Cancer.
用于肺部给药的纳米药物:克服呼吸道感染和肺癌治疗中的障碍
Pharmaceutics. 2024 Dec 11;16(12):1584. doi: 10.3390/pharmaceutics16121584.
4
Modulating Fibrotic Mechanical Microenvironment for Idiopathic Pulmonary Fibrosis Therapy.调节纤维化机械微环境用于特发性肺纤维化治疗
Adv Mater. 2024 Dec;36(50):e2407661. doi: 10.1002/adma.202407661. Epub 2024 Nov 12.
5
Mucus-Penetrable Biomimetic Nanoantibiotics for Pathogen-Induced Pneumonia Treatment.用于治疗病原体诱导性肺炎的黏液穿透仿生纳米抗生素
ACS Nano. 2024 Nov 12;18(45):31349-31359. doi: 10.1021/acsnano.4c10837. Epub 2024 Nov 1.
6
Phenotypic heterogeneity in bacteria: the rise of antibiotic persistence, clinical implications, and therapeutic opportunities.细菌表型异质性:抗生素耐药持久性的出现、临床意义和治疗机会。
Arch Microbiol. 2024 Oct 26;206(11):446. doi: 10.1007/s00203-024-04173-3.
7
Rapid precision targeting of nanoparticles to lung via caveolae pumping system in endothelium.纳米颗粒通过内皮细胞的小窝泵系统快速精准靶向肺部。
Nat Nanotechnol. 2025 Jan;20(1):144-155. doi: 10.1038/s41565-024-01786-z. Epub 2024 Oct 8.
8
Ultrasound-Responsive Nanocarriers Delivering siRNA and FeO Nanoparticles Reprogram Macrophages and Inhibit M2 Polarization for Enhanced NSCLC Immunotherapy.超声响应纳米载体递呈 siRNA 和 FeO 纳米颗粒重编程巨噬细胞并抑制 M2 极化增强 NSCLC 免疫治疗。
ACS Appl Mater Interfaces. 2024 Oct 23;16(42):56634-56652. doi: 10.1021/acsami.4c10036. Epub 2024 Oct 8.
9
Ultrasound-responsive nanocarriers with siRNA and FeO regulate macrophage polarization and phagocytosis for augmented non-small cell lung cancer immunotherapy.超声响应纳米载体携 siRNA 和 FeO 调控巨噬细胞极化和吞噬作用增强非小细胞肺癌免疫治疗
J Nanobiotechnology. 2024 Oct 7;22(1):605. doi: 10.1186/s12951-024-02883-w.
10
Sono-Triggered Biomimetically Nanoantibiotics Mediate Precise Sequential Therapy of MRSA-Induced Lung Infection.声触发仿生纳米抗生素介导耐甲氧西林金黄色葡萄球菌诱导的肺部感染的精确序贯治疗。
Adv Mater. 2024 Nov;36(46):e2403612. doi: 10.1002/adma.202403612. Epub 2024 Sep 30.